Compound W

Description

CompoundW is a topical formulation containing Salicylic Acid as the active ingredient. The product is presented in a liquid dosage form, with a net weight of 0.31 fluid ounces (9 mL). Salicylic Acid is known for its keratolytic properties, which aid in the treatment of various skin conditions.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

No teratogenic or nonteratogenic effects have been reported.

Dosage and Administration

The affected area should be washed thoroughly prior to treatment. If desired, the wart may be soaked in warm water for approximately 5 minutes to facilitate the application process. After soaking, the area must be dried completely.

Using the provided applicator, one drop of the medication should be applied at a time to ensure sufficient coverage of each wart. It is important to allow the application to dry completely before proceeding. This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Application on irritated skin or any area that is infected or reddened is prohibited due to the potential for exacerbating the condition. The product should not be applied to moles, birthmarks, warts with hair growth, genital warts, or warts located on the face or mucous membranes, as these may lead to adverse reactions or complications. Additionally, individuals with diabetes or poor blood circulation should not use this product, as it may pose significant risks to their health.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire and flame to prevent any risk of ignition.

The product should not be applied to irritated skin or any area that is infected or reddened. It is contraindicated for use on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, individuals with diabetes or poor blood circulation should refrain from using this product due to potential complications.

If discomfort persists after application, it is advised to discontinue use and consult a healthcare professional for further evaluation and guidance.

In the event of accidental ingestion, immediate medical assistance should be sought. Contact a Poison Control Center at 1-800-222-1222 or seek emergency medical help without delay.

Side Effects

Patients should be aware of the following adverse reactions associated with the use of this product.

Warnings indicate that the product is for external use only and is flammable; therefore, it should be kept away from fire and flame. It is contraindicated for use on irritated skin or any area that is infected or reddened. Additionally, the product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes. Patients with diabetes or poor blood circulation should also refrain from using this product.

During use, it is important to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it should be flushed with water for 15 minutes. Patients should also avoid inhaling vapors and ensure that the bottle is capped tightly and stored at room temperature, away from heat.

Patients are advised to stop using the product and consult a doctor if discomfort persists. Furthermore, the product should be kept out of reach of children. In case of ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions between this drug and laboratory tests. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Compound W (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risk to the fetus. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Skin discoloration has been reported in postmarketing experience, occurring during or after the use of the product. These events have been documented through voluntary reports and surveillance programs.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical assistance immediately or contact a Poison Control Center at 1-800-222-1222.

Patients should be instructed not to use the product on irritated skin or any area that appears infected or reddened. It is important to inform patients that the product should not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes. Additionally, patients with diabetes or poor blood circulation should be cautioned against using this product.

Healthcare providers should emphasize that if discomfort persists after using the product, patients should stop use and consult a doctor. While using the product, patients must avoid contact with their eyes; if the product accidentally enters the eye, they should flush it with water for 15 minutes. Patients should also be advised to avoid inhaling vapors from the product.

Finally, it is essential to instruct patients to cap the bottle tightly and store it at room temperature, away from heat sources, to maintain its efficacy and safety.

Storage and Handling

The product is supplied in a container that requires careful handling to maintain its integrity. It should be stored at room temperature, ensuring that it is kept away from excessive heat, specifically temperatures exceeding 37°C (99°F).

To ensure proper hygiene and prevent contamination, it is recommended to wipe the rim of the bottle with a paper towel between uses. This practice helps maintain the quality of the product throughout its usage.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Compound W, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)